Motley Fool Money cover image

Business Plans and Science Projects

Motley Fool Money

00:00

Breakthrough in GVHD Treatment

This chapter explores the recent approval of Rayoncil, a new treatment for GVHD in children under 12, showcasing its promising efficacy and survival rates. It also examines the financial implications of this therapy within healthcare systems, advocating for accessibility regardless of insurance status.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app